Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Article
  • Published:

Normal feeding behavior, body weight and leptin response require the neuropeptide Y Y2 receptor

Abstract

Neuropeptide Y (NPY), a 36-amino-acid peptide widely expressed in the brain1 is involved in many physiological responses2, including hypothalamic control of food intake and cardiovascular homeostasis. NPY mediates its effects through binding to the Y1, Y2 and Y5 G-protein-coupled receptors3,4,5,6. Little is known of the role of the Y2 receptor in mediating the different NPY effects. We inactivated the Y2 receptor subtype in mice and found that these mice developed increased body weight, food intake and fat deposition. The null mutant mice showed an attenuated response to leptin administration but a normal response to NPY-induced food intake and intact regulation of re-feeding and body weight after starvation. An absence of the Y2 receptor subtype also affected the basal control of heart rate, but did not influence blood pressure. These findings indicate an inhibitory role for the Y2 receptor subtype in the central regulation of body weight and control of food intake.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1: Y2 receptor disruption by homologous recombination.
Figure 2: The effect of normal-fat and high-fat diet on body weight and plasma composition.
Figure 3: Effects of starvation, NPY and leptin on food intake.

Similar content being viewed by others

References

  1. De Quidt, M.E. & Emson, P.C. Distribution of neuropeptide Y-like immunoreactivity in the rat central nervous system. II. Immunohistohemical analysis. Neuroscience 18, 545– 618 (1986).

    Article  CAS  Google Scholar 

  2. Wettstein, J.G., Earley, B. & Junien, J.L. Central nervous system pharmacology of neuropeptide Y. Pharmacol. Ther. 65, 397– 414 (1995).

    Article  CAS  Google Scholar 

  3. Rose, P.M. et al. Cloning and functional expression of a cDNA encoding a human type 2 neuropeptide Y receptor. J. Biol. Chem. 270, 22661–22664 (1995).

    Article  CAS  Google Scholar 

  4. Gerald, C. et al. Expression cloning and pharmacological characterization of a human hippocampal neuropeptide Y/peptide YY Y2 receptor subtype. J. Biol. Chem. 270, 26758–26776. (1995).

    Article  CAS  Google Scholar 

  5. Eva, C., Keinänen, K., Monyer, H., Seeburg, P. & Sprengel, R. Molecular cloning of a novel G-coupled receptor that may belong to the neuropeptide receptor familly. FEBS Lett. 271, 81–84 ( 1990).

    Article  CAS  Google Scholar 

  6. Gerald, C. et al. A receptor subtype involved in neuropeptide-Y-induced food intake. Nature 382, 168– 171 (1996).

    Article  CAS  Google Scholar 

  7. Dumont, Y., Fournier, A., St-Pierre, S. & Quirion, R. Comparative characterization and autoradiographic distribution of neuropeptide Y receptor subtypes in the rat brain. J. Neurosci. 13, 73–86 (1993).

    Article  CAS  Google Scholar 

  8. Naveilhan, P., Neveu, I., Arenas, E. & Ernfors, P. Complementary and overlapping expression of Y1, Y2 and Y5 receptors in the developing and adult mouse nervous system. Neuroscience 87, 289–302 (1998).

    Article  CAS  Google Scholar 

  9. Edvinsson, L., Ekblad, E., Hakanson, R. & Wahlestedt, C. Neuropeptide Y potentiates the effect of various vasoconstrictor agents on rabbit blood vessels. Br. J. Pharmacol. 83, 519– 525 (1984).

    Article  CAS  Google Scholar 

  10. Allen, J.M., Bircham, P.M., Edwards, A.V., Tatemato, K. & Bloom, S.R. Neuropeptide Y (NPY) reduces myocardial perfusion and inhibits the force of contraction of isolated perfused rabbit heart. Regul. Pept. 6, 247– 253 (1983).

    Article  CAS  Google Scholar 

  11. Pedrazzini, T. et al. Cardiovascular response, feeding behavior and locomotor activity in mice lacking the NPY Y1 receptor. Nature Med. 4, 722–726 (1998).

    Article  CAS  Google Scholar 

  12. Nilsson, T., You, J., Hedner, T. & Edvinsson, L. Characterization of neuropeptide Y receptors mediating contraction, potentiation and inhibition of relaxation. Blood Press. 5, 164– 169 (1996).

    Article  CAS  Google Scholar 

  13. Zhang, X. et al. Expression and regulation of neuropeptide Y Y2 receptor in sensory and autonomic ganglia. Proc. Natl. Acad. Sci. USA 94, 729–734 (1997).

    Article  CAS  Google Scholar 

  14. McDermott, B.J., Millar, B.C., Dolan, F.M. & Bell, D. Evidence for Y1 and Y2 subtypes of neuropeptide Y receptors linked to opposing postjunctional effects observed in rat cardiac myocytes. Eur. J. Pharmacol. 336, 257–265 (1997).

    Article  CAS  Google Scholar 

  15. Stanley, B.G., Magdalin, W., Seirafi, A., Nguyen, M.M. & Leibowitz, S.F. Evidence for neuropeptide Y mediation of eating produced by food deprivation and for variant of the Y1 receptor mediating this peptide's effect. Peptides 13, 581–587 (1992).

    Article  CAS  Google Scholar 

  16. Clark, J.T., Kalra, P.S., Crowley, W.R. & Kalra, S.P. Neuropeptide Y and human pancreatic polypeptide stimulate feeding behaviour in rats. Endocrinology 115, 427– 429 (1984).

    Article  CAS  Google Scholar 

  17. Marsh, D.J., Hollopeter, G., Kafer, K.E. & Palmiter, R.D. Role of the Y5 neuropeptide Y receptor in feeding and obesity. Nature Med. 4, 718–721 ( 1998).

    Article  CAS  Google Scholar 

  18. Kushi, A. et al. Obesity and mild hyperinsulinemia found in neuropeptide Y-Y1 receptor-deficient mice. Proc. Natl. Acad. Sci. USA 95, 15659–15664 (1998).

    Article  CAS  Google Scholar 

  19. Broberger, C., Landry, M., Wong, H., J.N., W. & Hokfelt, T. Subtypes Y1 and Y2 of neuropeptide Y receptor are respectively expressed in pro-opiomelanocortin- and neuropeptide-Y-containing neurons of the rat hypothalamic arcuate nucleus. Neuroendocrinology 66, 393–408 (1997).

    Article  CAS  Google Scholar 

  20. Schreyer, S.A., Wilson, D.L. & LeBoeuf, R.C. C57BL/6 mice fed high fat diets as models for diabetes-accelerated atherosclerosis. Atherosclerosis 136, 17 –24 (1998).

    Article  CAS  Google Scholar 

  21. Girardier, L., Clark, M.G. & Seydoux, J. Thermogenesis associated with spontaneous activity: an important component of thermoregulatory needs in rats. J. Neurophysiol. 488, 779–787 ( 1995).

    CAS  Google Scholar 

  22. Zhang, Y. et al. Positional cloning of the mouse obese gene and its human homologue. Nature 372, 425– 432 (1994).

    Article  CAS  Google Scholar 

  23. Erickson, J.C., Hollopeter, G. & Palmiter, R.D. Attenuation of the obesity syndrome of ob/ob Mice by the loss of neuropeptide Y. Science 274, 1704–1707 (1996).

    Article  CAS  Google Scholar 

  24. Stephens, T.W. et al. The role of neuropeptide Y in the antiobesity action of the obese gene product. Nature 377, 530 –532 (1995).

    Article  CAS  Google Scholar 

  25. Schwartz, M.W., Seeley, R.J., Campfield, L.A., Burn, P. & Baskin, D.G. Identification of targets of leptin action in rat hypothalamus. J. Clin. Invest. 98, 1101–1106 (1996).

    Article  CAS  Google Scholar 

  26. Chen, X., DiMaggio, D.A., Han, S.P. & Wessfall, T.C. Autoreceptor-induced inhibition of neuropeptide Y release from PC-12 cells is mediated by Y2 receptors. Am. J. Physiol. 273, H1737–H1744 (1997).

    CAS  PubMed  Google Scholar 

  27. Johansson, C. & Thorén, P. The effects of triiodothyronine (T3) on heart rate, temperature and ECG measured with telemetry in freely moving mice. Acta Physiol. Scand. 160, 133 –138 (1997).

    CAS  PubMed  Google Scholar 

  28. Johansson, C., Vennström, B. & Thorén, P. Evidence that decreased heart rate in thyroid hormone receptor α1 deficient mice is an intrinsic defect. Am. J. Physiol. 44, R640–R646 (1998).

    Google Scholar 

Download references

Acknowledgements

We thank P. Mombaerts for the gift of the IRES/tau/lacZ plasmid. We thank M. Byström, M. Edlund, H. Fält, O. Karlsson, M. Lindberg and U. Marklund for input in the creation and characterization of the polyclonal antibodies, and L. Amrut Fors for determination of the plasma components. We thank J. Wagner and S. Nyström for comments on the manuscript. This research was supported by the Swedish Medical Research Council and Kapten Arthur Ericssons Foundation to P.E. P.N. was a fellow of the WennerGren Foundation and Karolinska Institute, and J.M.C. was a fellow of the European Molecular Biology Organization.

Author information

Authors and Affiliations

Authors

Corresponding authors

Correspondence to Philippe Naveilhan or Patrik Ernfors.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Naveilhan, P., Hassani, H., Canals, J. et al. Normal feeding behavior, body weight and leptin response require the neuropeptide Y Y2 receptor. Nat Med 5, 1188–1193 (1999). https://doi.org/10.1038/13514

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1038/13514

This article is cited by

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing